THE STRONGMAN IMMUNE SYSTEM: INFLAMMATION, DEFENSE AND ADAPTATION | Episode 4: Myokines: How Skeletal Muscle Communicates with Metabolism and the Immune System

Skeletal muscle as a secretory organ

Skeletal muscle is simultaneously a force-producing system, a metabolic reservoir, and a tissue that communicates through signaling molecules. Recognition of this third role has substantially changed exercise physiology. When a strongman lifts a heavy implement, contractile fibers do more than generate mechanical tension: their activity alters energy-substrate availability, intracellular signaling, and, in some settings, the release of molecules that act locally or in distant tissues. Some are called myokines. This term does not describe one hormone or imply that every candidate molecule originates exclusively in muscle. Classical definitions focused on peptides produced and released by muscle fibers with autocrine, paracrine, or endocrine actions. More recent research also distinguishes factors secreted by other cells residing in muscle, including fibroblasts, endothelial cells, and immune populations. Establishing the source matters before assigning a circulating protein to working muscle with certainty [1,2].

Autocrine signaling acts on the secreting cell, whereas paracrine signaling influences nearby cells. Endocrine signaling concerns distant targets, commonly reached through circulation. Yet finding more of a substance in plasma does not automatically prove a functional endocrine effect; researchers need evidence of source, receptor, target, and biological consequence. Myokines and exerkines should therefore not be treated as perfect synonyms. Exerkines, in a broad definition, include exercise-associated signals originating in multiple organs, such as adipose tissue and liver. An athlete may display systemic molecular changes after lifting, but not every altered circulating factor can be attributed to contracting muscle. This distinction prevents oversimplified claims about strength hormones [1,3].

Muscle and immunity communicate bidirectionally. Contraction can alter the mediators available to immune cells, while resident and recruited immune populations may influence muscular remodeling, metabolism, and adaptation. A 2024 Cell Metabolism review described immunoregulatory contributions to exercise adaptation while emphasizing that mechanisms identified in experimental models have not all been reproduced in maximal human training. For strongman, myokines therefore represent a promising field rather than a validated table converting log-press repetitions into an ideal interleukin concentration. Running, cycling, and conventional resistance-exercise studies generate hypotheses, but their differences in duration, intensity, and recruited muscle mass must remain explicit [4].

How muscle contraction becomes a biological signal

Contraction begins with electrical excitation and changes in intracellular calcium that permit interactions among contractile proteins. Simultaneously, energetic ratios, mitochondrial activity, glucose and glycogen availability, and mechanical signaling through the cytoskeleton and extracellular matrix change. Such stimuli can influence gene expression and protein synthesis. However, altered transcription does not prove that a protein was secreted, and secretion does not guarantee a measurable effect at a distant site. Experiments must distinguish messenger RNA in a muscle biopsy, local protein abundance, and circulating concentration. When a study reports increased myokine expression after squats, the reader should check which level was actually measured. Conflating them is a common source of exaggerated claims about communication among organs [1,5].

Mechanical loading and metabolic demand are different concepts. A near-maximal single may generate great tension briefly, whereas a timed medley can challenge metabolism for longer with relatively lighter implements. Both belong to strongman, but identical secretion time courses should not be assumed. Exercise familiarity also matters. A competitor experienced in a particular event may respond differently from a novice performing the movement for the first time. Myokine research is marked by such heterogeneity, and a 2024 meta-analysis did not identify consistent moderators of the responses to resistance exercise among the factors tested. Failure to demonstrate a relationship does not mean intensity is biologically irrelevant; it means existing evidence cannot yet provide a simple predictive rule [3].

Sampling time can change the apparent conclusion of an experiment. Some myokines rise immediately after exercise and return toward baseline during subsequent hours, whereas others have delayed kinetics. A meta-analysis comparing exercise modes reported that circulating responses are often transient and molecule-dependent. A study collecting blood two minutes after the final repetition cannot be directly compared with one sampling three hours later as though both represented the same physiological stage. Concentration also reflects distribution, clearance, and changes in plasma volume. A circulating signal may originate from several tissues. Demonstrating a causal link between contraction and muscle secretion requires appropriate methods and controls [5].

Interleukin-6: the best-known myokine example

Interleukin-6, abbreviated IL-6, appears in medicine as an inflammatory mediator but also has a major history as a product of working muscle. Classical research showed that skeletal muscle can contribute to increased circulating IL-6 during exercise, supporting the idea of muscle as a secretory organ. IL-6 is not exclusively muscular, however; immune and other cells also produce it in various contexts. One plasma increase therefore does not identify its source or define the effect as beneficial or harmful. Under some conditions IL-6 contributes to metabolism and inflammatory regulation, while persistent signaling in other settings can participate in pathology. Timing, receptors, and physiological environment are essential. Saying IL-6 is always pro-inflammatory is as incomplete as saying it is always anti-inflammatory [1,6].

During contraction, muscle IL-6 expression may be influenced by energetic status, glycogen availability, and intracellular signaling. These relationships have been studied extensively in endurance exercise and cannot automatically be transferred to a deadlift single. A session containing many contractions over an extended interval differs from one maximal attempt with long rests. IL-6 may participate in substrate regulation and metabolic communication, but an acute increase cannot guarantee improved insulin sensitivity in a given person. Immediate responses must not be confused with months-long training adaptations, and clinical metabolic investigations answer different questions from mechanistic exercise experiments. For strongman, IL-6 is best considered a context-dependent signal, not a session-efficiency score [1,6].

Ringleb and colleagues' 2024 FASEB Journal meta-analysis synthesized immediate immunoregulatory myokine responses to resistance exercise. For IL-6, the average standardized effect was positive, with Hedges' g approximately 0.45 and a 95% confidence interval from 0.29 to 0.61, while between-study heterogeneity was high. A detectable average effect therefore does not describe every protocol or athlete identically. The authors could not identify a robust dose-related moderator that simply predicted the magnitude of change. There is an important distinction between saying IL-6 can increase after resistance exercise and claiming that one exact strongman protocol will produce a beneficial increase of known magnitude. The former is supported by available studies; the latter requires direct evidence [3].

IL-6 may be investigated through plasma concentration, gene expression, and receptor-related signaling. These are distinct endpoints. Greater blood concentration may reflect production, distribution, or clearance, while increased gene expression in a biopsy does not establish systemic secretion. Membrane-receptor pathways and trans-signaling may also have different consequences. Treating one value as a generic measure of inflammation ignores this biology. In a symptomatic athlete, clinical evaluation should not be reduced to IL-6, and there is no standard indication to measure it after every session in a healthy competitor. Research is valuable because it can distinguish mechanisms, not because it creates an instant diagnosis.

Why one molecule can have apparently opposite effects

A cytokine is not a simple good-or-bad switch. Its effects depend on the receptor-bearing cell, signal strength and duration, other molecules present, and tissue condition. During exercise, metabolic and endocrine changes create an environment unlike systemic infection or chronic inflammatory disease. Accordingly, an IL-6 result must be interpreted in the context in which it was measured. A concentration observed after hard training cannot automatically be equated with the same concentration in a febrile patient. Some pathways overlap, but organism-level consequences may differ. This is the key to understanding myokines: mechanisms are context-dependent rather than permanently assigned a positive or negative label [1,6].

The effects of IL-6 on mediators such as IL-1 receptor antagonist helped generate the hypothesis that muscle activity can support certain systemic anti-inflammatory processes. Yet a molecular sequence should not be converted into a promise of preventing every inflammatory disease. A mediator may rise without demonstrating fewer symptoms, cardiovascular events, or infections. Acute responses do not establish durable changes in baseline physiology. For strongman, research from other exercise modes can offer a plausible account of muscle-immune communication, while individual interventions still need outcomes relevant to health and athletic performance. Respecting the limits of inference preserves rather than diminishes the importance of the discovery [3,6].

IL-1 receptor antagonist, IL-10, and inflammatory regulation

Interleukin-1 receptor antagonist, or IL-1ra, can limit certain interleukin-1 effects through competition for its receptor. In exercise physiology it matters because the body activates not only inflammatory signals but also counter-regulatory mechanisms. The 2024 resistance-exercise meta-analysis found a positive average immediate effect on IL-1ra concentrations. Yet the number of contributing studies and heterogeneity prevent the result from becoming a prescription. Five deadlift sets cannot be assumed to create optimal tissue protection, and IL-1ra measurement cannot substitute for clinical evaluation. One molecule represents only a small part of regulatory networks. Its meaning depends on source, receptor, timing, and interaction with other pathways. Observations among healthy volunteers do not establish an identical therapeutic result for patients with inflammatory disorders [3].

IL-10 has important immune-regulatory functions. Popular accounts sometimes describe it as an anti-inflammatory hormone that necessarily rises after every workout, but not all evidence supports that promise. In the resistance-exercise meta-analysis, the immediate pooled effect for IL-10 was not statistically significant. This does not prove that the molecule is irrelevant or rule out later, local, or protocol-dependent responses. It means that the analyzed data did not establish a robust immediate increase. Interpreting that absence as failed adaptation would be as mistaken as promising a guaranteed rise. Ideally, studies need repeated sampling and functional measures rather than a single post-exercise specimen [3].

Ratios between cytokines, such as IL-6/IL-10, are sometimes used in discussions of inflammatory balance. They may have exploratory value but are not validated diagnoses of an athlete's immune condition. Numerator and denominator can vary for different reasons, and a ratio may change because only one component changed. Analytical methods, units, and values near assay detection limits introduce further complexity. No universal cytokine-ratio threshold determines whether a strongman should perform another yoke round. Workload decisions should be based on goals, performance, symptoms, and appropriate clinical evaluation when needed. Molecular research cannot offer a safety formula without validation.

IL-15: links between muscle and immune populations

Interleukin-15 contributes to the biology of several lymphocyte populations, including natural killer cells and antigen-experienced T cells. Muscle researchers have investigated it as a possible link among contraction, metabolism, and immunity. Experimental work suggests roles in muscle homeostasis and adipose-tissue regulation, but human evidence about systemic secretion after exercise is inconsistent. The 2024 meta-analysis found a small-to-moderate positive immediate effect following resistance exercise, based on relatively few studies and broad uncertainty. A rise is not necessarily beneficial, and athletes should not attempt to maximize the molecule. Effects depend on receptor expression, tissue context, and duration of stimulation. These are reasons for further investigation rather than an immunological training recipe [3,7].

Calling IL-15 a myokine requires attention to the demonstrated source and study design. Detecting the molecule in muscle or observing a plasma increase does not identify skeletal muscle fibers as the exclusive origin. Human experiments may measure total circulating concentration without determining which tissue contributed. This matters when changes in NK function are attributed to one exercise. Demonstrating a complete causal sequence would require evidence of muscular production and release, receptor interaction, and functional consequences in the target cells. Without each link, the model can be plausible but not clinically established. Strength training should not be described as precise natural IL-15 administration because the biological dose remains incompletely known.

Strongman events with different durations might influence IL-15 signaling differently, but the hypothesis has not been validated across sport-specific protocols. When researchers report a post-exercise increase, readers need information about recruited muscles, repetitions, collection timing, and participant characteristics. Training history and metabolic context may modify the outcome. Without clinically relevant infection or cellular-function results, claims about stronger immunity are premature. IL-15 is better regarded as one candidate mediator of tissue communication with complex actions than as a score of workout quality.

Irisin: an attractive hypothesis with measurement problems

Irisin is associated with the FNDC5 precursor protein and gained prominence through research into muscle, adipose tissue, and energy metabolism. Experimental studies suggested possible roles in metabolic adaptation, but interpretation of circulating concentrations in humans has been complicated by analytical controversy. Researchers have questioned the identification of the peptide and specificity of antibodies in some commercial assays. Mass-spectrometry studies provided evidence that irisin can be detected in human blood, while reported concentrations and reproducibility still differ across laboratories. An ELISA result should therefore not become an instant judgment about training effectiveness or metabolic health. Biological attractiveness does not become evidence simply through repetition in promotional material [8,9].

Irisin illustrates how science changes when measurement instruments are challenged. Antibodies that bind unrelated proteins can yield precise-looking numbers without measuring the intended molecule. Sample preparation for mass spectrometry may introduce variable losses and other sources of uncertainty. A claim that irisin rose by 200 percent after exercise is difficult to interpret without assay details, baseline value, and validation data. Neither the molecule's existence nor the problems of measuring it establish an ideal strongman protocol. The reasonable conclusion is that the biology is interesting but comparisons between studies require caution. Standardization and clinical outcomes are necessary before irisin could become a practical athlete-monitoring measure [8,9].

Irisin is sometimes said to convert white fat into brown fat predictably after every workout. This is an oversimplification of experimental literature on adipose-tissue phenotypes and ignores differences between animal models, cultured cells, and humans. Adipose metabolism is influenced by numerous factors rather than one molecule. Body-composition changes in a large athlete depend on energy intake, activity, metabolic health, and other influences. There is no evidence that an irisin measurement following farmers carry can forecast an individual's fat loss over a defined period. Proposed mechanisms must be distinguished from confirmed clinical effects, especially when the topic is used to market supplements or dramatic recomposition protocols.

BDNF, apelin, and other inter-organ signals

Brain-derived neurotrophic factor, or BDNF, is associated with neuronal function and nervous-system adaptation, and also appears in studies of exercise and skeletal muscle. Not every rise in circulating BDNF should be attributed to muscular production. The factor can originate from several compartments, and serum and plasma measurements are not equivalent. Some actions may be local rather than clearly demonstrated endocrine effects. BDNF is an interesting topic for motor learning and brain health, but no circulating level directly predicts an athlete's next log-press performance. Association with neuroplasticity does not establish that every exercise-related rise produces a quantified improvement in technique or cognition [2,7].

Apelin participates in cardiovascular and metabolic signaling and has been investigated as a potential exercise-associated mediator. Experimental results are promising in several metabolic and aging-related contexts, but tissue source, human effects, and clinical applications require careful qualification. A factor may have multiple origins, and increased muscular expression does not prove that muscle explains all circulating changes. Strongman involves meaningful cardiovascular and metabolic demands, yet no validated relationship converts farmers-walk time into an apelin dose that prevents disease. Translational research must move from identifying signals to demonstrating meaningful health effects [7].

Other candidates include SPARC, decorin, meteorin-like, myostatin, follistatin, leukemia inhibitory factor, and FGF21. They do not share the same level of evidence concerning muscular origin, systemic secretion, receptors, or clinical outcomes. Some are studied primarily in muscle-growth regulation, others in metabolism, tissue remodeling, or inter-organ communication. Placing them in one list should not imply that all rise after every exercise bout or are uniformly beneficial. Rigorous discussion separates well-supported mechanisms from hypotheses based on animal models, cell cultures, or uncertain assays. Such a hierarchy produces a more realistic picture of skeletal muscle as a secretory tissue [2,7].

Myostatin, follistatin, and muscle-growth regulation

Myostatin is a member of the TGF-β family involved in restraining muscle growth through signaling pathways that influence tissue size and function. It has attracted considerable interest in strength sports because genetic alterations reducing its function can produce striking muscular phenotypes in certain models. Yet this observation does not justify self-directed myostatin blockade. Adaptation depends on many interconnected pathways, and interventions targeting one molecule may have systemic consequences. Circulating concentrations and muscular expression represent only parts of a larger receptor-ligand network. Exercise research may observe changes under particular conditions, but no validated conversion links one biomarker reduction to kilograms gained on a deadlift. Assay differences and participant heterogeneity complicate comparisons further [2,7].

Follistatin can bind selected proteins within activin-related signaling networks and can influence pathways that involve myostatin. It is frequently described as myostatin's perfect opposite, but the biological system is not a simple two-component balance. Effects depend on molecular forms, receptors, tissues, and duration. A post-exercise rise cannot automatically demonstrate superior hypertrophy, while a low value does not establish failed adaptation. In strongman, practical progress indicators remain sporting performance, workload tolerance, and health, rather than unsupervised manipulation of the pathway. Pharmaceutical research targeting myostatin signaling is different from safe training prescription. Confusing these domains can create risky medical and sporting conclusions.

Decorin is an extracellular-matrix protein involved in tissue organization and interactions with signaling molecules. It has been investigated in skeletal muscle and exercise, with some studies suggesting links to remodeling. However, a molecule present in tissue is not automatically a circulating endocrine hormone with demonstrated systemic actions. Source, molecular form, and measurement method matter. Mechanical stress travels through muscle fibers, tendons, and matrix during strongman events, making interest in such proteins understandable. Yet there is no evidence that decorin measurements can select an ideal yoke intensity or diagnose inadequate recovery. These findings contribute to mechanistic understanding without constituting a validated prediction tool.

Myokines and glucose metabolism

During muscular contraction, glucose uptake can increase through mechanisms involving GLUT4 transporters and activity-dependent signaling. Some myokines participate in metabolic communication, but their roles should not be conflated with contractile and insulin-dependent glucose transport mechanisms. Exercise can influence insulin sensitivity and metabolic health through many processes, including adaptations in muscle, blood flow, and body composition. The entire benefit should not be assigned to one burst of IL-6. Results from sedentary individuals or those with metabolic disorders may differ from highly trained strength athletes. A study showing improved glucose uptake after resistance training must be interpreted through population, intervention duration, and method, not only the mediator selected for a headline [1,7].

Glycogen stores glucose in muscle and liver and helps support activity. Muscle glycogen availability can influence certain contraction-associated signaling responses, including IL-6 in some experimental models. Yet a strongman should not deliberately pursue extreme glycogen depletion to generate a hypothetical immune signal. Preparation aims to sustain performance and health, with energy availability matched to demands. A brief maximal event has a different energetic profile from an extended loading circuit; not all workouts exhaust stores similarly. When discussing myokines, a signal's sensitivity to metabolic stress must be distinguished from nutritional advice. The fact that a marker increases under one condition does not mean that condition should be imposed systematically.

Adipose tissue is also a secretory organ, producing adipokines and other molecules that participate in metabolic and immune communication. The relationship between muscle and fat is bidirectional. High body mass in strength athletes can reflect widely different proportions of muscle and adipose tissue, and metabolic health cannot be deduced from body weight alone. Some myokines have been investigated in relation to adipose-associated inflammation, but a mechanism does not equal a cure. Evaluating metabolic health requires appropriate clinical indicators and individualized training choices. Strongman athletes are not a single metabolic phenotype; body composition, lifestyle, and medical histories vary. Sweeping generalizations are unsafe [2,7].

Connections with bone, tendon, and vascular tissue

Muscle interacts mechanically and biochemically with bone, and exercise can influence bone remodeling through loading and signaling. Some exercise-associated molecules are being investigated as inter-tissue messengers, although not all have demonstrated endocrine roles in humans. Yoke and loaded-carry events impose significant musculoskeletal demands, but bone adaptation cannot be predicted from one myokine. Mechanical factors, loading history, age, and hormonal health matter. Treating a molecular change as proof that a tendon became stronger during one session would confuse levels of analysis. Tendons can adapt on different timescales from muscle, and immediate performance does not guarantee tolerance of sudden workload increases.

Blood vessels respond to exercise through changes in flow, shear stress, and local signaling. Muscle-derived or other mediators may contribute to cardiovascular communication, but their origins must be demonstrated. Heavy strongman attempts can generate substantial blood-pressure demands, and cardiovascular health cannot be assessed through the statement that myokines are beneficial. Athletes with elevated blood pressure need clinical evaluation regardless of their personal records. Habitual exercise may have broad benefits, but a maximal attempt is not equivalent to a controlled therapeutic intervention. Myokines form part of biological explanation, not a substitute for medical monitoring or risk-factor management.

Connections with innate and adaptive immunity

Mediators associated with muscular work can influence immune populations under certain conditions, but antimicrobial defense cannot be inferred from the blood concentration of a single myokine. Neutrophils, macrophages, and lymphocytes respond to signaling networks, tissue characteristics, and previous immune experience. A rise in IL-15 does not automatically establish better NK-cell control of a virus, just as altered IL-6 does not demonstrate new pathogen-specific antibodies from B cells. Immunity is distributed across anatomical compartments, and both source and destination of signals matter. Exercise can modify cell traffic and molecular environments without introducing novel antigen information. This distinction is essential when products are marketed as universal immune boosters [3,4].

Some muscle signals contribute to regulating local responses after mechanical stress. Resident and recruited immune cells may participate in debris clearance and remodeling, yet processes documented after experimental injury are not identical to well-tolerated habitual training. Local inflammation can serve adaptive functions in certain contexts, while excessive or persistent activity may accompany disease. The next episode will explore this distinction. Here the central point is that myokines contribute to communication rather than independently determine health. A post-exercise mediator measurement cannot replace evaluation of symptoms, functional capacity, or pre-existing conditions [4].

Adaptive immunity depends on antigen experience and interactions among antigen-presenting cells, T cells, and B cells. Training can influence neuroendocrine conditions and the circulation of some immune populations, but myokines do not substitute for vaccination. A molecule rising after lifting does not independently provide specificity against a pathogen. This is particularly relevant to athletes traveling to competitions. Appropriate medical prevention, hygiene, and evaluation of respiratory illness remain important regardless of strength. Associations between exercise and selected immune functions do not create invulnerability. Responsible communication avoids promises extending beyond the methods used in research.

Quantitative evidence: what average effects demonstrate

Hedges' g expresses a standardized difference relative to variability, not a concentration in picograms per milliliter or a probability of disease. In the 2024 meta-analysis, the average effect for IL-6 after resistance exercise was approximately 0.45, and for IL-1ra approximately 0.49. Smaller positive effects appeared for IL-15 and TNF-α, whereas the confidence interval for IL-10 included no effect. These findings do not mean every participant followed the same pattern. Substantial heterogeneity shows that study outcomes varied. Most importantly, a standardized effect on molecular concentration cannot be converted directly into infection risk or strength progress. Readers must distinguish the statistical endpoint from its biological interpretation [3].

A confidence interval describes uncertainty around an average estimate within a model, whereas a prediction interval attempts to capture variation in effects across future comparable contexts. A positive average may coexist with a prediction interval including negative values, meaning a new protocol could behave differently. This occurs in parts of the myokine literature, where exercises and participants vary considerably. Focusing only on a p value while ignoring uncertainty is inadequate. In strength sports, the difference between average tendency and individual prediction is crucial. A coach cannot tell an athlete that a molecule certainly increased by 45 percent because a study reported a standardized effect of 0.45. That would be a fundamental statistical error [3].

Subgroup analyses can explore effects of age, sex, experience, intensity, or volume. Yet failure to identify a significant moderator does not establish that no biological relationship exists. Datasets may be too small or heterogeneous, and training variables may be reported inconsistently. The resistance-myokine meta-analysis identified no consistent moderators for the tested outcomes, limiting attempts to infer dose-response rules. This matters because it prevents constructing an optimal myokine workout from insufficient data. In strongman, workload can be described in kilograms, repetitions, seconds, and distance, but none alone fully captures biological demand. Better studies must describe dose and context before proposing prescriptions [3].

Why a single myokine cannot measure health

A biomarker is useful when its relationship to the clinical or research question has been demonstrated. IL-6, IL-15, and other mediators are fascinating mechanistic variables but not validated readiness scores for strongman. Concentration depends on production, distribution, elimination, and plasma volume. Collection time, recent activity, and energy status can influence post-workout results. One measurement cannot determine where a molecule originated or which function it currently performs. A physician evaluating fever or unusual pain asks different questions from a researcher investigating muscle secretion. Ordering an experimental myokine panel instead of appropriate clinical assessment could delay a relevant diagnosis.

Measurement utility also depends on reproducibility. Commercial kits with different antibodies, standards, and processing procedures may yield substantially different results. Some proteins circulate near detection limits, and complex biological samples can interfere with assays. Irisin provides a particularly clear example, but the principle is broader. Many decimal places do not establish accuracy. Researchers should report analytical methods, reagent batches, quality control, and sample handling. In sport, unvalidated tests used to justify major training changes may generate false alarms or reassurance. Biological complexity cannot be replaced by an equally complex laboratory invoice.

Extrapolating from association to causation is another concern. If more active people show different myokine levels and better metabolic health, it does not follow that the molecule caused the difference. Diet, body composition, age, and medical history may differ between groups. Demonstrating a causal pathway requires suitable experimental interventions or tests of relevant biological targets, followed by careful translation from cells and animals to humans. Observational findings can generate valuable hypotheses but cannot establish treatment by themselves. The exceptional characteristics of elite strongman athletes are not adequate controls for concluding that one myokine explains competitive success.

Strongman: from maximal singles to metabolic medleys

A deadlift single involves very high tension over a short interval, whereas a medley combines locomotion, loading, and rapid transitions. These contexts may differ in contraction number, duration, and metabolic stress, all potentially relevant to myokine signaling. Yet no evidence establishes that one is superior for anti-inflammatory secretion without direct comparisons. Sporting preparation should prioritize the demands of actual events, technique, and tolerance. Athletes should not overhaul programs to pursue a marker with no validated clinical threshold. Researchers can instead ask whether clearly described protocols produce different responses and whether those differences matter for health or performance. At present the answer remains incomplete.

Exercises recruiting large amounts of muscle may produce different signals from more isolated movements, but active muscle mass cannot be inferred solely from implement weight. Farmers walks involve grip, postural stabilization, and locomotion, whereas log press includes other movement patterns and transitions. Technical experience changes efficiency, and failed attempts increase total demands. Mechanistic investigations should report repetitions, duration, rests, relative intensity, and sampling time. A simple heavy-versus-light classification loses important information, while total tonnage alone misses other differences. Protocol descriptions must be detailed enough for replication and interpretation.

Recovery between events and days adds complexity. A one-day contest may produce an acute profile unlike a multi-day event involving travel, sleep disruption, and altered meals. A myokine concentration at the end of the second day reflects several influences, not just the final log press. Without baseline information, separating them becomes difficult. Strongman research therefore needs both ecologically valid competition protocols and controlled comparisons. Ideally, biochemical measures would be integrated with external workload, perceived exertion, and clinical information without turning one marker into a diagnosis. Direct evidence remains insufficient for precise claims.

Three examples of responsible interpretation

First, imagine a competitor performing ten heavy singles with generous rest and reporting moderate muscular fatigue. Nothing in that observation establishes how much IL-6 was released or whether IL-1ra rose. Blood samples would need comparison with suitable baselines and interpretation according to timing and other conditions. Even an increased molecular signal would not demonstrate that the session prevented infections. For training decisions, performance, technique, and symptoms are more directly actionable. Myokine studies may explain mechanisms, but they do not automatically dictate the next single. This distinction prevents programs from being overloaded with interventions driven by unvalidated biomarkers.

Second, suppose an athlete completes a circuit of bags, stones, and carries and then shows a higher inflammatory mediator concentration. Neither disease nor perfect adaptation follows automatically. An acute response may be physiological, but its meaning depends on molecule, time course, and clinical context. Chest pain, fever, severe weakness, or other important symptoms should prompt medical assessment rather than reassurance that this is merely a myokine. Conversely, preserved function and an uncomplicated recovery can inform practical decisions without proving ideal immunity. Less dramatic conclusions are often closer to biological reality [4].

Third, after several weeks of training, a competitor improves strength and selected metabolic indicators. Progress cannot automatically be attributed to one myokine because neural, muscular, circulatory, and behavioral adaptations coexist. Changes in IL-15 or irisin might accompany improvement without establishing causality. Mechanistic claims would require targeted investigation. In sport, performance and health can be followed together without inventing a single molecular explanation for every improvement. Multiple mechanisms may contribute to one result, and that complexity does not diminish progress.

What constitutes the dose of a muscle-derived signal?

External exercise dose can be described by sets, repetitions, implement mass, distance, and duration. Internal demand includes the athlete's physiological experience, perceived effort, metabolic changes, and baseline condition. Two people can perform the same external task with markedly different relative stress. A meta-analysis failing to identify robust moderators does not authorize a formula converting tonnage into myokine concentration. Such a rule would require standardized, longitudinal measurements and relevant outcomes. For coaches, the sound approach remains rational progression and health monitoring rather than chasing an unvalidated ideal IL-6 zone. The question is open and deserves direct research.

Another research direction examines multiple secreted factors and their interactions simultaneously. Yet measuring dozens or hundreds of proteins increases the risk of chance discoveries unless multiple comparisons are controlled. Omics projects can generate useful hypotheses, but independent replication and functional validation are essential. A predictive model trained on a small sample may describe that group well while failing on new athletes. Strongman's relatively small elite population magnifies this challenge. International collaboration, standardized sampling, and publication of null findings would strengthen the evidence base. The aim is not collecting the largest possible molecular catalog but identifying verifiable mechanisms that matter for health and performance.

Comparing endurance research: transfer is not automatic

Myokines have been studied extensively during running and cycling, where exertion can continue for long periods and metabolic demand can be standardized through oxygen uptake or mechanical power. Strongman instead combines brief near-maximal efforts with intense circuits and changing movements. A 2026 endurance-exercise meta-analysis documented immediate increases in several mediators, including IL-6, IL-10, IL-1ra, IL-8, IL-15, and TNF-α. These findings complement resistance-exercise research but should not be merged into a universal conclusion for every event. For example, a detectable IL-10 effect in an endurance synthesis and no significant immediate effect in the resistance meta-analysis do not invalidate one another. Populations, protocols, methods, and sampling times differ [3,10].

Exercise duration can influence energy availability and endocrine responses, but workload is described differently across modes. Cycling intensity may be standardized against a power benchmark; a strongman medley combines masses, distances, and technical difficulties. Even two circuits lasting the same time can involve different musculature, eccentric contractions, and rests. Endurance dose-response relationships cannot simply be copied into strongman. Controlled comparisons could match duration while varying load and contraction patterns, measuring molecular responses alongside sporting outcomes. Until such evidence exists, extrapolation should be labeled as extrapolation rather than presented as a medical prescription.

Sampling schedules further complicate comparison. Endurance studies may include repeated recovery measurements while some resistance investigations collect only immediately after exercise. For mediators with delayed peaks, that difference can change pooled findings. Recent meals, hydration, and training history add variation. Popular accounts often report only that molecule X rose after exercise. Better interpretation specifies the activity, duration, sample timing, and methodological limitations. A twenty-second yoke event and a two-hour volume session are not physiologically interchangeable simply because both involve strength [5,10].

Myokines, adaptation, and inflammation: avoiding conceptual confusion

Some myokines are investigated as contributors to muscular remodeling, but strength adaptation cannot be explained through a single mediator. Hypertrophy, structural changes, neural efficiency, and movement coordination interact. An athlete may improve log press without a measurable increase in one circulating molecule, while a biomarker may rise without producing additional performance. Molecular research must distinguish association from causal mediation. If an intervention changes both performance and IL-6, the latter has not necessarily caused the entire improvement. Appropriate experiments are needed to test the proposed links. Sound explanation describes networks and recognizes that numerous components have not been directly tested in strongman.

Post-exercise inflammation is often discussed alongside myokines, but the concepts are not identical. Some myokines participate in metabolic signaling without inflammation being their dominant function, while circulating cytokines may originate outside muscle. Exercise-induced muscle damage is not necessary for every adaptation, and soreness is not a reliable measure of training quality. Tenderness after lifting may reflect mechanical and neurological factors rather than an optimal myokine profile. The next episode will distinguish physiological responses from illness and signs requiring medical assessment. Here it is enough to recognize that signaling and inflammation intersect without being the same phenomenon [4,11].

Indiscriminately blocking all inflammatory reactions is sometimes proposed as a recovery strategy. This ignores that certain inflammatory processes contribute to normal tissue remodeling and antimicrobial defense. It does not follow that clinically indicated treatment of inflammatory disease should be avoided for fear of reducing sporting adaptation. Medication decisions depend on medical indications and individual risks. Athletes should not discontinue prescribed treatments to preserve a myokine peak. Sustainable performance and health are joint goals, while pharmaceutical interventions must be assessed separately from ordinary training strategies.

Methodological questions: source, target, and receptor

To describe a myokine as an endocrine mediator, researchers ideally need evidence that muscle produces it, releases a meaningful quantity, that it reaches a target tissue, and produces an effect through an identifiable mechanism. These steps call for different methods, from biopsies and cell experiments to flux measurements and functional testing. One increase in blood concentration demonstrates none of the entire chain. Many molecules have several sources, and some act locally without clearly established systemic secretion. Recent reviews therefore classify candidate mediators by strength of evidence rather than popularity. IL-6 has a better-developed physiological base for certain functions, whereas other candidates remain exploratory. Clear evidence tiers are useful for public-facing scientific writing [2,7].

Cell experiments may expose targets to concentrations far greater than those occurring in human blood. An effect at those doses cannot automatically be extrapolated to quantities released by working muscle. Animal models differ from humans in metabolism and gene regulation, while pharmaceutical manipulation may not reproduce natural contraction-dependent secretion. These distinctions limit claims about exercise molecules as treatments. Some pathways may become valuable therapeutic targets, but clinical development requires evidence of efficacy and safety. Exploratory research is not a reason for healthy athletes to experiment with substances altering hormonal or immune signaling.

Laboratory validation involves specificity, sensitivity, reproducibility, and testing for interference. Cross-study comparisons must consider assay standards, units, and sample-processing delay. Proteins may circulate in bound forms, and assays may detect different fractions. Commercial kits can produce results that are not directly comparable. Rigorous reporting links numerical precision to information about the method generating the number. For myokines this is especially important because conclusions may depend on small changes. An unvalidated result cannot support broad prescriptions for strength athletes, however dramatic it appears.

What a strongman-specific experimental protocol could look like

A comparative project might study three sessions: heavy singles with ample rest, a timed loading-and-carrying medley, and a conventional high-volume workout. Participants should be described by training experience, age, sex, body composition, and health. Blood collection at standardized times before and after activity would be combined with attention to meals and preceding exercise. Validated assays could assess selected mediators such as IL-6, IL-1ra, and IL-15 alongside confounding variables. Results should distinguish circulating concentration from muscular expression and report confidence intervals rather than only p values. Clinical applications would require outcomes meaningful for health, not biomarkers alone. This research would provide a stronger foundation than uncritical transfer from cycling [3].

External loading should be described precisely: implement mass, repetitions, event duration, rests, and failed attempts. Perceived effort and environmental conditions may also be informative. These measurements are not assumed to predict secretion; they make hypotheses testable. Real competitions introduce travel, sleep loss, and psychological stress, modifying biological context. Laboratory studies offer control while field studies provide ecological relevance, and both can contribute to different questions. Collaboration among competitors, coaches, immunologists, and biostatisticians could improve direct applicability without reducing the sport to one marker.

Researchers should avoid selecting only spectacular results. Measuring ten myokines at multiple times creates opportunities for chance differences. Preregistered analysis, complete reporting, and independent replication would strengthen conclusions. Small elite samples limit statistical power and individual variation may be considerable. Even so, a well-described pilot study has value if it is not presented as definitive proof. Strength sports need clear, reproducible questions rather than promises of calculating the perfect myokine response from one session. This discipline is crucial for responsible translation from laboratory research to sports medicine.

Practical implications for coaches and athletes

For coaches, the most useful application is not selecting exercises according to presumed myokine output, but recognizing that muscle communicates with the rest of the body. Strength sessions alter more than local mechanical properties, and workload management must consider tolerance, fatigue, and general condition. This does not provide exact rest or volume rules based on IL-6. Programs should primarily reflect actual events, technique, and progression. Immunological research can motivate questions but cannot justify arbitrary tonnage increases. Fever, major weakness, or significant respiratory symptoms require appropriate evaluation rather than maximal lifting intended to stimulate myokines.

A training journal can record exercise type, duration, volume, unsuccessful attempts, perceived difficulty, and symptoms. These data may help characterize individual responses but cannot calculate molecular secretion. Research involving biological sampling should also document collection time. An immediate plasma change differs from a persistent difference after weeks, and some signals return to baseline before the next workout. Separating observation, hypothesis, and decision is valuable. I slept poorly and performed below expectations is an observation; IL-6 caused the result is an untested hypothesis. A prudent program adjustment can make sense without inventing its exact molecular explanation.

Athletes with metabolic concerns require clinically validated assessment of health history and risks. Myokines matter for understanding how exercise interacts with metabolism, but routine testing is not a substitute for appropriate evaluation of blood glucose, blood pressure, or other indicated measures. A large athlete can be extraordinarily strong while still requiring medical monitoring. Reducing every metabolic problem to a shortage of one myokine ignores disease complexity. At the same time, suitable physical activity remains important for health. The useful conclusion is not that myokines solve every problem, but that they represent one set of pathways through which skeletal muscle participates in whole-body regulation.

Risks of commercial extrapolation

Supplement marketing may borrow myokine terminology to imply that a product amplifies the benefits of exertion. Yet mechanisms in cells or animals do not guarantee human effectiveness or safety. Therapeutic claims require evidence regarding dose, target, clinical benefit, and risks. A product promising to increase irisin without a validated assay faces another problem: it is unclear whether the reported measurement reflects the molecule accurately. Similarly, a mediator change after ingesting a supplement does not prove disease prevention or superior hypertrophy. Competitive athletes must also consider contamination risks, contraindications, and applicable anti-doping requirements. This article does not recommend substances intended to manipulate myokine signaling.

Methodological appendix: how to read myokine studies

Start by identifying the population. Sedentary volunteers, recreational athletes, older adults, and elite strongman competitors may differ greatly in training capacity and biology. A valid finding in one population is not automatically confirmed in another. Next examine the exact exercise protocol. Ten conventional repetitions at a defined relative intensity may be unlike a twenty-meter yoke event. Third, check when specimens were collected. Molecules can follow different rising and falling trajectories, so one immediate measurement cannot describe the whole recovery period. Fourth, identify the endpoint: messenger RNA, intramuscular protein, circulating concentration, or biological function. Each may be informative but should not be confused with the others.

Another critical question is whether the investigators demonstrated muscle as the source. Sometimes measurements occur only in plasma even though the factor can originate in several tissues. Other studies include biopsies showing muscular expression but not the amount entering circulation. Arteriovenous sampling and functional approaches can provide further evidence, although they involve experimental challenges. Readers should separate three claims: a molecule is associated with exercise, muscle fibers secrete it, and it causes a proposed clinical effect. These are different levels of proof. A paper investigating only the first claim may still be valuable; the error is claiming that it demonstrated all three.

Statistical evaluation also shapes confidence. Small samples and numerous simultaneous tests increase opportunities for unstable estimates and chance discoveries. Wide confidence intervals show uncertainty even when the average effect looks interesting. Study heterogeneity complicates generalization, and subgroup analyses may be underpowered. Check whether primary outcomes were prespecified, null findings were reported, and bias risks were discussed. Meta-analysis is a powerful instrument but does not automatically turn weak studies into certainty. Strongman research must pay particular attention to athlete selection, event description, and relative intensity. A carefully bounded conclusion can be valuable even when modest.

Finally identify the clinical outcome. A myokine increase after lifting does not necessarily demonstrate fewer infections, faster recovery, or greater hypertrophy. Such claims require health, functional, or performance outcomes, ideally in designs capable of addressing causality. Mechanistic research provides plausible explanations and guides future experiments, but cannot replace clinical evidence. Readers need not choose between unquestioning enthusiasm and wholesale rejection. They can accept established mechanisms while remaining cautious about unproven applications. That is how a genuine scientific discovery should be used in sport.

An interdisciplinary account of strength

Myokine physiology connects biomechanics, metabolism, endocrinology, and immunology. One strongman event can be described by force applied to an object, energy consumed in muscle, chemical signals released, and systemic physiological responses. None of these descriptions cancels the others. Each has distinct measurement tools and limitations. One researcher may study immune-cell traffic after log press, another energy expenditure, while the coach evaluates technique and speed. Integrating these perspectives could improve understanding without reducing performance to a single hormone. The aim is not the most complicated molecular diagram but an explanation that can be tested and used appropriately.

One useful direction is comparing molecular signals after familiar and unfamiliar events. Technical familiarity can change efficiency and local tissue disturbance, which might influence selected markers. That possibility does not prove that experienced athletes have healthier responses to all demands. They can generate greater absolute loads and face different metabolic challenges from beginners. Research should account for relative intensity, technical history, and failed attempts before separating adaptation from strength capacity. Until such data exist, familiarity and signaling remain related but distinct phenomena.

Further interpretation: negative findings are useful

A study reporting no significant change in a candidate myokine is not automatically a failed experiment. It may reveal that the molecule does not respond robustly to the tested protocol, that its response occurs at a different time, or that the measurement lacked sufficient precision. Distinguishing these possibilities depends on sample size, collection timing, and analytical quality. Null results can help prevent the field from building theory exclusively from dramatic positive reports. When only studies with large apparent effects are discussed, readers may incorrectly conclude that every bout of exercise produces a major endocrine event. Good scientific communication includes results that contradict expectations and explains their uncertainty without concealing them.

Replication is especially important for candidate molecules measured by commercially available assays. If laboratories use reagents that recognize different molecular forms, apparently contradictory results may reflect methodology rather than biological differences. Independent verification using orthogonal analytical techniques can improve confidence. Cross-study standards and transparent reporting are therefore scientific priorities, not minor technical details. A purported biomarker should not become part of routine strongman management while its measurement remains unreliable. The inconvenience of uncertainty is preferable to confidently changing training on the basis of an unstable number.

Another challenge is determining whether a signal reflects adaptation or simply disturbance. A large acute change may accompany an unusually demanding session without proving superior long-term benefit. Conversely, a training program can improve performance while producing a smaller acute molecular response as the athlete becomes familiar with the work. Neither pattern can be evaluated by the size of one cytokine peak alone. Longitudinal studies should measure actual changes in strength, tissue function, and health while examining candidate mediators. Such designs could distinguish signals accompanying adaptation from those necessary for it, though proving mediation remains difficult.

Ultimately, the physiology of muscle-derived signals supports a more sophisticated understanding of exercise than the simple opposition between inflammation and recovery. Contracting muscle communicates with multiple tissues through overlapping pathways, while the effects depend on timing and context. This does not imply that any one molecule must be maximized, suppressed, or measured after every training session. For strongman, the best application today is thoughtful programming, appropriate clinical monitoring, and curiosity about mechanisms that may be clarified by future research. Scientific rigor can coexist with enthusiasm for strength without offering unsupported biochemical shortcuts.

Readers comparing the different episodes of this series should keep their questions separate. Innate immunity concerns rapid barriers and responses; adaptive immunity concerns antigen specificity and memory; myokines concern signaling associated with active muscle; inflammation involves processes of recognition, amplification, control, and resolution. These domains interact but are not synonyms. An increase in IL-6 cannot independently diagnose infection, prove the creation of immune memory, or predict muscle growth. Maintaining the distinctions allows the same physiological event to be examined from several perspectives without treating each new measurement as a complete explanation.

The next conceptual step is to examine post-exercise inflammation itself. Physiological signaling, muscle soreness, significant tissue injury, infection, and chronic inflammatory disease may share some laboratory features while requiring very different conclusions. Distinguishing them demands clinical context and careful attention to warning signs, not just a comparison of cytokine concentrations. Strongman provides demanding examples because high mechanical loads can produce transient disturbances in otherwise healthy athletes. These observations deserve scientific explanation without normalizing dangerous symptoms or diagnosing disease from every biomarker fluctuation.

Future directions: from molecular networks to verifiable outcomes

An important research goal is distinguishing factors that accompany exercise from factors that actually mediate adaptation. A protein may rise after a session because it reflects a process without being necessary for the process to occur. Demonstrating causal mediation would require evidence that modifying its pathway changes an outcome predictably. Such experiments are difficult in humans because directly manipulating signaling can create ethical and safety concerns. Longitudinal studies reveal temporal associations, while biological models may suggest mechanisms, but neither alone solves the challenges of clinical translation. Strongman research could start with standardized observations following clearly described events without pretending that every causal connection has already been identified.

Health relevance presents another essential question. A statistically detectable molecular change may have no established effect on performance, symptoms, or disease risk. Conversely, important clinical outcomes can arise through many pathways not fully captured by the chosen myokine panel. Studies integrating functional measures, metabolic health, and sporting performance may yield more useful relationships. Comparison groups and clear eligibility criteria are necessary, especially in a sport with wide variation in body mass and experience. Recruiting only successful competitors can introduce selection bias because individuals who failed to tolerate demanding preparation are missing. Interpretation must account for the resulting limitations.

Analytical instruments are becoming increasingly sophisticated, but technological precision does not guarantee that the research question is relevant. Mass spectrometry may identify peptides with high specificity, yet without hypotheses about source tissues, receptors, and biological effects it remains primarily descriptive. Computational models may discover correlations among dozens of proteins and training volume without demonstrating that proteins cause performance changes. Applied science requires separating discovery from validation. A new hypothesis may deserve investigation without being marketed immediately as therapy. For athletes, restraint prevents premature recommendations while increasing the value of future research.

Public communication should also avoid personifying molecular pathways. IL-6 does not know that a competitor is preparing for a contest, and irisin does not decide to transform metabolism. Such expressions may work as educational metaphors but become misleading if they obscure biological conditions. Mediators act through biochemical interactions, with consequences dependent on receptors, cell types, and environments. Training programs are planned intentionally by people; molecular responses emerge from systems without deliberate intention. Accessible explanations need not abandon accuracy. Strongman is already spectacular enough without fabricated molecular certainty.

In everyday coaching, an evidence-based culture separates sporting aims from molecular markers. Progress toward a log-press record is guided by technique, capacity, and recovery. A medical concern is assessed through symptoms and clinically indicated tests. A myokine experiment investigates defined mechanistic questions. All are legitimate but should not be conflated. Treating myokines as components of biological communication improves understanding without creating an obligation to measure every signal after each session. Until specific applications are validated, performance programming remains better grounded in functional outcomes and health.

Interdisciplinary work also requires clear language. Metabolism researchers, immunologists, sports physicians, and biomechanists may use the word activation for different processes. It might describe gene expression, protein secretion, cell trafficking, or clinical manifestations. Without specifying the level, discussion becomes ambiguous. Strongman research would benefit from shared protocols, explicit definitions, and complete reporting of limitations. Conclusions should match measurements: a plasma concentration supports a claim about concentration; a clinical outcome can support a health-related claim. This hierarchy helps prevent genuine discoveries from being transformed into slogans about athletic invulnerability.

Biological variability across athletes

Large differences among individuals are not merely obstacles to analysis. They can reveal how starting health, training history, age, and body composition alter responses. Two athletes completing the same farmers-carry distance may experience different relative intensity and metabolic demand. Even when the external work is standardized, one may need more attempts or use a less efficient technique. The resulting myokine concentrations cannot be predicted solely from implement weight. Future studies should report individual response distributions alongside average values. A mean effect is informative, but personalized predictions require separate validation.

Some physiological differences may also reflect the time of day and preceding activity. A session after long work hours is not necessarily equivalent to a controlled morning test with standardized meals and sleep. This matters particularly in strongman, where athletes often combine professional obligations, travel, and training. Researchers should describe the circumstances rather than treating them as irrelevant noise. In practice, the complexity makes routine myokine testing even less suitable as a simple readiness metric. A change in one marker may reflect several overlapping influences.

Baseline inflammation is another source of variation. Chronic illness, recent infection, medication, and metabolic characteristics can influence circulating mediators independently of exercise. An abnormal value obtained after training must therefore be interpreted cautiously and should not automatically be normalized as an athletic adaptation. Significant medical symptoms require appropriate evaluation even in very strong athletes. Conversely, ordinary transient post-exercise changes are not proof of disease. Keeping these possibilities separate prevents both underdiagnosis and unnecessary alarm.

Claims about sex and age differences must also be proportionate to the data. Small studies often contain unequal participant numbers and cannot estimate reliable subgroup effects. Biological variability exists within demographic categories as well as between them. A finding among young male participants cannot simply be declared universal for female athletes or older adults. The absence of a significant moderator in a meta-analysis may reflect limited statistical power rather than biological sameness. Researchers should state the population examined and avoid confident extrapolation where direct studies are lacking.

Differences between acute and chronic exercise are also central. Immediate secretion may be transient, whereas long-term changes in metabolism and health emerge through many repeated processes. A large acute cytokine response is not necessarily evidence of superior adaptation, and a small response is not necessarily evidence of ineffective training. Chronic improvements can occur through neural, vascular, muscular, and behavioral routes without an identifiable persistent increase in any one circulating myokine. Only appropriate longitudinal designs can examine whether molecular changes track or mediate durable outcomes.

For applied strongman coaching, these uncertainties reinforce a practical principle: use each tool for the question it can answer. Event times and loads describe sporting ability. Symptoms and clinical investigations contribute to health assessment. Experimental cytokine measurements describe selected biological signals. None should be promoted as a complete substitute for the others. The athlete benefits most when these perspectives are coordinated with realistic limits. That is the foundation of evidence-based performance rather than a limitation to be embarrassed about.

Closing synthesis

Skeletal muscle is a dynamic secretory tissue, and myokines offer a scientifically important explanation for communication among metabolism, immunity, and other organs. The evidence is strongest for selected mechanisms, particularly aspects of muscle-associated IL-6 signaling, while many candidate factors require better source attribution, assay validation, and human studies. Resistance exercise changes some circulating mediators, but patterns vary and cannot be predicted precisely for every strongman event. Molecular change is not automatically clinical benefit. The safest scientific position is neither to dismiss myokines nor to use them as marketing instruments, but to investigate them with methods appropriate to their complexity.

A final distinction concerns the meaning of statistical effect size. A large percentage change may arise from a tiny baseline and have uncertain physiological importance. A standardized effect is not an absolute concentration change, and statistical significance does not guarantee clinical benefit. If researchers measured one circulating protein, they have not necessarily demonstrated muscular secretion or improved protection against infection. Critical interpretation requires examining the assay, the participant population, the exercise protocol, and the timing of samples. This allows readers to appreciate real molecular discoveries without accepting every dramatic extrapolation made from them. Strongman audiences deserve the same care with biological measures as coaches apply to accurately recording competitive loads.

Myokine signals also interact with other physiological systems that should not be reduced to one number. The nervous system coordinates movement, blood vessels distribute substrates, endocrine pathways regulate energy availability, and local immune cells participate in tissue surveillance. A change in one mediator takes place against this wider background. It may be important without being the sole cause of adaptation. When a competitor progresses in strength, many mechanisms can be involved; when symptoms arise, clinical assessment must consider possibilities beyond exercise physiology. Treating molecular research as one layer of explanation is more useful than expecting it to replace the full picture.

Direct strongman studies would help define which observations transfer from conventional resistance exercise. The sport involves maximal singles, prolonged carries, loaded movement, and complex event combinations. These produce different mixtures of tension, contraction frequency, metabolic demand, and psychological stress. Researchers could compare carefully documented protocols while acknowledging participant differences. Appropriate sampling schedules would reveal how quickly candidate signals appear and subside. Yet even such research would need independent clinical outcomes to establish health benefits. Molecular profiles cannot be transformed automatically into treatment recommendations or guarantees of immunity.

Evidence grading should remain explicit. A factor detected in human plasma with a validated assay is not necessarily proven to originate from muscle. A factor produced by muscle may still lack evidence of a distant physiological effect. Demonstrating receptor engagement is different again from showing improved health in a randomized clinical intervention. These stages can be valuable separately, but should not be collapsed into one claim. The most scientifically productive research agenda identifies missing links and designs studies to test them. Presenting uncertainty transparently encourages better investigation rather than undermining scientific interest.

The distinction between physiological and pathological processes becomes particularly important when athletes report soreness or fatigue after demanding sessions. Molecular signaling after exercise is not equivalent to bacterial infection or a chronic inflammatory disorder. Conversely, potentially dangerous symptoms should not be dismissed as routine adaptation. Myokine measurements do not replace assessment of severe weakness, chest pain, fever, or other warning signs. The next installment examines that boundary through clinical signs, laboratory markers, and the biology of tissue repair. Understanding muscle secretion helps explain why exercise can cause transient molecular changes without making every such change a disease.

Taken together, these perspectives support a grounded view of strength physiology. Muscle can act as a secretory tissue, and its activity contributes to communication among organs. Some signaling mechanisms are well established; others remain provisional because sources, receptors, or assays are incompletely characterized. A single intense session can produce measurable changes without establishing long-term clinical benefit. Coaches should therefore prioritize safe and effective programming, while researchers continue to test the networks linking muscle and immunity. A sophisticated understanding of molecular biology strengthens the science of sport precisely when it avoids overpromising.

A final practical safeguard is to separate the research setting from individual medical advice. A study may intentionally expose volunteers to demanding exercise and collect serial samples under supervision, but that does not mean an athlete should reproduce the protocol to manipulate cytokines independently. Clinical symptoms, medication history, and prior health conditions change the relevant decision. Scientific exploration and everyday coaching operate with different responsibilities. Properly interpreted, myokine research enriches understanding of muscle-organ communication without replacing validated clinical measures or the ordinary principles of safe, progressive training.

The distinction between a measurable signal and a useful intervention is central. A molecule can respond reproducibly to exertion without offering a target worth manipulating. Only carefully designed clinical research can determine whether changing its pathway leads to meaningful benefits that outweigh risks for a defined population.

Responsible explanation does not diminish the discovery of myokines. Recognition of skeletal muscle as a secretory organ has genuinely expanded our understanding of exercise, metabolism, and immunity. That makes inflated promises worth challenging. Saying that IL-6 can rise after resistance exercise is well supported; promising that this rise will eliminate chronic inflammation is not. Studying irisin is worthwhile; presenting its concentration as a validated commercial test of body recomposition is not. Readers should ask whether a paper observed molecular change, demonstrated a function, or documented a clinical benefit. These evidence levels must remain distinct.

Conclusion: muscle transmits information, not simple commands

Myokines illustrate links among mechanical tension, metabolism, and immune signaling. IL-6 has a strong physiological basis as a contraction-associated mediator, while IL-1ra, IL-15, and other candidates reveal complex networks. However, response size and meaning depend on protocol, methods, and participants, and direct strongman evidence remains limited. Myokines cannot be reduced to good-or-bad labels, and no biomarker substitutes for clinical evaluation. Coaches should program toward sporting goals while protecting health without inventing immune formulas. Researchers need to establish sources, receptors, functions, and clinical outcomes. The next episode will explain why post-training inflammation is not automatically disease [1–4].

Selected scientific references

[1] Pedersen, B. K., & Febbraio, M. A. (2008). Muscle as an endocrine organ: focus on muscle-derived interleukin-6. Physiological Reviews, 88, 1379–1406. https://doi.org/10.1152/physrev.90100.2007

[2] Pedersen, B. K., & Febbraio, M. A. (2012). Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nature Reviews Endocrinology, 8, 457–465. https://doi.org/10.1038/nrendo.2012.49

[3] Ringleb, M., et al. (2024). Beyond muscles: Investigating immunoregulatory myokines in acute resistance exercise: A systematic review and meta-analysis. The FASEB Journal, 38, e23596. https://doi.org/10.1096/fj.202301619R

[4] Langston, P. K., & Mathis, D. (2024). Immunological regulation of skeletal muscle adaptation to exercise. Cell Metabolism, 36, 1175–1183. https://doi.org/10.1016/j.cmet.2024.04.001

[5] Exercise training mode effects on myokine expression in healthy adults: A systematic review with meta-analysis. (2024). Journal of Sport and Health Science. https://doi.org/10.1016/j.jshs.2024.04.005

[6] Pedersen, B. K., & Fischer, C. P. (2007). Physiological roles of muscle-derived interleukin-6 in response to exercise. Current Opinion in Clinical Nutrition and Metabolic Care. https://pubmed.ncbi.nlm.nih.gov/17414493/

[7] Exercise-induced myokines in metabolic regulation: mechanisms, mimetics, and translational potential. (2026). https://pubmed.ncbi.nlm.nih.gov/42315824/

[8] Jedrychowski, M. P., et al. (2015). Detection and quantitation of circulating human irisin by tandem mass spectrometry. Cell Metabolism, 22, 734–740. https://doi.org/10.1016/j.cmet.2015.08.001

[9] Albrecht, E., et al. (2020). Irisin: Still chasing shadows. Molecular Metabolism. https://pubmed.ncbi.nlm.nih.gov/32180552/

[10] Ringleb, M., et al. (2026). Circulating Myokine Responses to Acute Endurance Exercise and Their Role in Immunoregulation. The FASEB Journal, 40, e71536. https://doi.org/10.1096/fj.202504780R

[11] Peake, J. M., et al. (2017). Muscle damage and inflammation during recovery from exercise. Journal of Applied Physiology, 122, 559–570. https://doi.org/10.1152/japplphysiol.00971.2016